Small molecules targeting heterotrimeric G proteins.

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• G protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
• Approximately 30-40% of current medications target GPCRs, highlighting their significance in medicine.
• GPCRs mediate cellular signals via interactions with various proteins, notably heterotrimeric G proteins.

Purpose of the Study:

• To review the development of small molecules that directly target G proteins.
• To emphasize their use as pharmacological tools for dissecting GPCR-G protein complex activation mechanisms.
• To explore applications in understanding GPCR biology and related diseases.

Main Methods:

• Review of existing literature on small molecule development targeting G proteins.
• Analysis of studies utilizing these molecules to investigate GPCR-G protein interactions.
• Examination of in vitro and in vivo data on the therapeutic potential of G protein-targeting agents.

Main Results:

• Small molecules directly targeting G proteins are emerging as valuable research tools.
• These molecules aid in understanding complex GPCR signaling pathways, including functional selectivity and preassembly.
• Evidence supports the potential of these small molecules in treating various GPCR/G protein-associated diseases.

Conclusions:

• Direct G protein-targeting small molecules represent a significant advancement in GPCR research.
• They provide novel avenues for dissecting GPCR activation mechanisms and signaling diversity.
• These compounds hold promise for future therapeutic strategies in a range of diseases.